Singapore, Singapore

Andre Boon Hwa Choo

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Andre Boon Hwa Choo

Introduction

Andre Boon Hwa Choo is a notable inventor based in Singapore, known for his contributions to the field of biotechnology. He holds a total of 7 patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

One of his latest patents is focused on Anti-CEACAM6 antibodies and methods of use. This invention relates to an antigen-binding protein, or an antigen-binding fragment, that binds to CEACAM6. The heavy chain variable domain includes specific amino acid sequences for VHCDR1, VHCDR2, and VHCDR3. Additionally, the light chain variable domain comprises unique sequences for VLCDR1, VLCDR2, and VLCDR3. This invention also encompasses compositions that include the antigen-binding protein, methods for its use in cancer treatment, prevention, or detection, and a kit containing the antigen-binding protein or its fragment.

Career Highlights

Throughout his career, Andre has worked with prominent organizations such as the Agency for Science, Technology and Research and Singapore Health Services Pte Ltd. His work in these institutions has significantly contributed to his expertise and the development of his innovative patents.

Collaborations

Andre has collaborated with notable coworkers, including Heng Liang Tan and Hau Wan Leung, further enhancing the impact of his work in the field.

Conclusion

Andre Boon Hwa Choo's contributions to biotechnology through his patents and collaborations highlight his role as a significant innovator in the industry. His work continues to pave the way for advancements in cancer treatment and detection.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…